| Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma HS Kantheti, MA Hale, S Pal Choudhuri, H Huang, X Wang, Y Zolghadri, ... International Journal of Molecular Sciences 25 (12), 6619, 2024 | | 2024 |
| Increasing the Dye Payload of Cetuximab-IRDye800CW Enables Photodynamic Therapy A Nguyen, C Bhandari, M Keown, A Malkoochi, M Quaye, D Mahmoud, ... Molecular Pharmaceutics, 2024 | | 2024 |
| The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial D Hsiehchen, MS Beg, R Kainthla, J Lohrey, SM Kazmi, L Khosama, ... Nature communications 15 (1), 2178, 2024 | | 2024 |
| AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer M Marquez-Palencia, L Reza Herrera, PK Parida, S Ghosh, K Kim, ... Cancer research 84 (5), 675-687, 2024 | 1 | 2024 |
| Nuclear localization of Argonaute 2 is affected by cell density and may relieve repression by microRNAs KC Johnson, A Kilikevicius, C Hofman, J Hu, Y Liu, S Aguilar, J Graswich, ... Nucleic acids research 52 (4), 1930-1952, 2024 | 8 | 2024 |
| PD‐L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self‐Delivery C Bhandari, A Moffat, N Shah, A Khan, M Quaye, J Fakhry, S Soma, ... Advanced Healthcare Materials, 2304340, 2024 | 5 | 2024 |
| Deep Learning–Based H-Score Quantification of Immunohistochemistry-Stained Images Z Wen, D Luo, S Wang, R Rong, BM Evers, L Jia, Y Fang, EV Daoud, ... Modern Pathology 37 (2), 100398, 2024 | 4 | 2024 |
| Abstract A033: Blocking TNF-a producing macrophage activates antitumor immunity in pancreatic cancer via IL33 A Dixit, P Provenzano, A Sarver, J Zettervall, H Huang, K Zheng, ... Cancer Research 84 (2_Supplement), A033-A033, 2024 | | 2024 |
| Imaging of cellular dynamics in vitro and in situ: from a whole organism to sub-cellular imaging with self-driving, multi-scale microscopy S Daetwyler, H Mazloom-Farsibaf, FY Zhou, D Segal, E Sapoznik, ... bioRxiv, 2024.02. 28.582579, 2024 | 1 | 2024 |
| 598 Bemcentinib+ pembrolizumab show promising efficacy in metastatic NSCLC harbouring mutations associated with poor prognosis: exploratory sub-analysis from the BGBC008 trial … G Gausdal, DR Micklem, M Blø, A Rayford, D Alzhanova, N Madeleine, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer S Bhalla, FJ Fattah, C Ahn, J Williams, A Macchiaroli, J Padro, M Pogue, ... Lung Cancer 182, 107291, 2023 | 5 | 2023 |
| Nuclear Localization of Argonaute is affected by Cell Density and May Relieve Repression by microRNAs DR Corey, KR Johnson, J Hu, A Kilikevicius, C Hofman, Y Liu, S Aguilar, ... | | 2023 |
| Method of Selecting Patients for Treatment with a Combination of an AXL Inhibitor and an Immune Checkpoint Modulator J Lorens, D Micklem, H Li, LIU Zhida, J Minna, R Brekken US Patent App. 17/920,442, 2023 | | 2023 |
| Loss of Smad4 induces SPP1 secretion and immunosuppressive myeloid cell formation in pancreatic ductal adenocarcinoma GZ Murimwa, F Rossi, HK Fleming, Z Yazgan, D Alzhanova, H Huang, ... Cancer Research 83 (7_Supplement), 3641-3641, 2023 | | 2023 |
| Aberrantly exposed phosphatidylserine as a drug delivery target in pancreatic cancer NZ Phinney, X Huang, ML Trawick, K Pinney, R Brekken Cancer Research 83 (7_Supplement), 1272-1272, 2023 | | 2023 |
| Targeting anticancer agents to the tumor microenvironment with cathepsin B cleavable drug-linker conjugates of phosphatidylserine-binding proteins Y Deng, JW Ford, JM VanNatta, CJ Maguire, D Mondal, NZ Phinney, ... Cancer Research 83 (7_Supplement), 1545-1545, 2023 | | 2023 |
| AXL as a therapeutic target in STK11 mutant NSCLC M Blø, A Rayford, N Madeleine, F Gärtner, D Bohan, N Ruggio, H Li, ... Cancer Research 83 (7_Supplement), 3245-3245, 2023 | 1 | 2023 |
| Pleiotrophin drives a prometastatic immune niche in breast cancer D Ganguly, MO Schmidt, M Coleman, TVC Ngo, N Sorrelle, ... Journal of Experimental Medicine 220 (5), e20220610, 2023 | 4 | 2023 |
| Abstract B016: Pleiotrophin drives a pro-metastatic immune niche within the breast tumor microenvironment D Ganguly, M Schmidt, M Coleman, TV Ngo, N Sorrelle, A Dominguez, ... Cancer Research 83 (2_Supplement_2), B016-B016, 2023 | | 2023 |
| Cell competition shapes metastatic latency and relapse K Kim, H Huang, PK Parida, L He, M Marquez-Palencia, TC Reese, ... Cancer discovery 13 (1), 85-97, 2023 | 8 | 2023 |
